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Proteins that modify the structure of chromatin are known to be important
for various aspects of metazoan biology including development, disease
and possibly ageing. Yet functional details of why these proteins are
important, i.e. how their action influences a given biological process, are
lacking. While it is now possible to describe the biochemistry of how these
proteins remodel chromatin, their chromatin binding profiles in cell lines,
or gene expression changes upon loss of a given protein, in very few cases
has this easily translated into an understanding of how the function of that
protein actually influences a developmental process. Given that many chro-
matin modifying proteins will largely exert their influence through control
of gene expression, it is useful to consider developmental processes as
changes in the gene regulatory network (GRN), with each cell type exhibit-
ing a unique gene expression profile. In this essay we consider the impact
of two abundant and highly conserved chromatin modifying complexes,
namely the nucleosome remodelling and deacetylation (NuRD) complex
and the polycomb repressive complex 2 (PRC2), on the change in GRNs
associated with lineage commitment during early mammalian development.
We propose that while the NuRD complex limits the stability of cell states
and defines the developmental trajectory between two stable states, PRC2
activity is important for stabilizing a new GRN once established. Although
these two complexes display different biochemical activities, chromatin
binding profiles and mutant phenotypes, we propose a model to explain
how they cooperate to facilitate the transition through cell states that is
development.
Introduction
Each multicellular organism arises from a single cell.
During development, as cells divide and their numbers
multiply, different groups of cells take on different
roles. These different roles require cells to be able to
respond to different signals, and often they will need
to acquire drastically different morphologies to per-
form their roles adequately. Nearly all cells within an
organism carry the same genome, yet each cell type
has a distinct profile of gene expression to make it
most fit for purpose: each cell type will have a distinct
combination of genes which are on, off, primed or
oscillating. Despite all of this heterogeneity and poten-
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tial variability, animal development is normally very
predictable. This suggests that the ability to transit
between distinct gene expression profiles in a specific
order is highly robust.
One of the most powerful available models to study
differentiation between stably self-renewing cell types
is the embryonic stem (ES) cell. ES cells are cells
derived from the inner cell mass of a blastocyst-stage
embryo [1]. They can self-renew indefinitely in vitro,
and are prized because they promise the potential to
form any type of somatic tissue (i.e. they are pluripo-
tent). Indeed, the field of stem cell biology holds
immense potential to positively impact human health
through regenerative medicine [2–4], where stem cells
could, in theory, be used to create any tissue type of
need for the medical and/or pharmaceutical industry.
However, in order to achieve this very broad aim, we
must be able to both understand and control human
development. In order to control development, we
must be able to understand and control gene expres-
sion.
From observation, we know that an individual cell
is able to react appropriately to signals from its sur-
roundings whilst also being able to act upon internal
programmes. Thus, it is clear that cells are capable of
integrating multiple forms of information and are able
to compute decisions based on this. We know that
ordinary, wild-type ES cells are capable of self-renewal
and differentiation. Furthermore, they have the capa-
bility to differentiate into more than one cell type,
such that in certain culture conditions they can appar-
ently choose between different fates, resulting in heter-
ogeneous cultures. That is, cells which are exposed to
seemingly identical conditions can exhibit different
behaviours. So the question here is: how are these cells
choosing one fate over another? Or, more precisely, by
what mechanisms are the cells integrating and inter-
preting signals from their surroundings, and how can
these interpretations result in different behaviours
between cells in a clonal cell population?
One of the key mechanisms in allowing cells to
respond to instructions and to modulate gene tran-
scription is the chromatin modifying machinery. Com-
plexes such as the nucleosome remodelling and
deacetylation (NuRD) complex and the polycomb
repressive complexes (PRC1/PRC2) are capable of
remodelling and/or modifying chromatin, and all play
important roles in cell differentiation. Previous reviews
have focused on the physical changes to chromatin
which accompany differentiation. In this review we
consider what roles chromatin modifying complexes
play in ES cell differentiation, but with a focus on the
potential effects of these complexes on the dynamics of
the transcription factor gene regulatory network
(GRN) rather than on the physical chromatin itself.
Mouse embryonic stem cells
Mouse ES cells have a relatively open chromatin struc-
ture which becomes denser upon differentiation. Dur-
ing differentiation, there is a wide-scale repression of
ES-cell-state-related genes. This is achieved by a com-
bination of factors, but the two we shall consider most
closely here are histone modifications and nucleosome
remodelling.
As well as allowing genome packaging, nucleosomes
are employed in the regulation of transcription [5–7].
Nucleosome-level regulation is broadly concerned with
controlling access of polymerases and transcription
factors, increasing or decreasing the likelihood of tran-
scription. This can be achieved by changing the loca-
tion of nucleosomes with a nucleosome remodeller
(e.g. by Chd4 in the NuRD complex or Brg1 in esBAF
[5,8,9]) or by chemically modifying the histones at
their N-terminal tails or globular domains (e.g.
H3K27me3 by PRC2 [10,11]). All chromatin modifica-
tions like this are reversible and dynamic, although
some can be maintained over many generations, giving
rise to a type of cellular memory [12].
In standard culture conditions, and even in the rela-
tively homogeneous, chemically defined two-inhibitor
(2i) culture condition [13,14], mouseES cells are not
completely homogeneous [15–18]. If we have a popula-
tion of ES cells which spawn from a single cell, which
self-renew, and which are morphologically indistin-
guishable from one another, we will nevertheless find
subpopulations with discretely different gene expres-
sion profiles. Furthermore, these different patterns of
expression can bias the cell towards self-renewal or dif-
ferentiation, but at the same time the patterns can be
dynamic and transient, creating temporal windows-of-
opportunity for choosing a particular fate [19,20]. This
already gives us some insight to the dynamics of the
system.
The heterogeneity of gene expression seen in ES cells
is often attributed to a combination of cellular noise,
oscillating circuits [21] and various switches embedded
in the GRN [19,22]. The concept of cellular noise
intends to capture all of the factors which lead to ran-
dom variability in cells – something of a formal
acknowledgement of the messiness of biology [23–25].
Within this, sources of noise are often classed as
intrinsic or extrinsic, although the boundary between
the classes can be blurred [26–28].
In practice, factors which introduce intrinsic noise
introduce variation to intracellular events which
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should be identically regulated (such as the random
diffusion of macromolecules causing localized changes
in the equilibria of biomolecular reactions [29]).
Extrinsic noise refers to the variation of identically
regulated events across a population of cells. Examples
of this include differences in cell-cycle stage, differ-
ences in organelle distribution, or any environmental
stimuli. This physical messiness gives a plausible driver
for ES cell heterogeneity.
One of the most interesting aspects of ES cell heter-
ogeneity is the fact that cells appear to be able to
express many genes at broadly discrete levels (we very
often find two steady states – to simplify, ON or OFF)
and that, when measured across multiple generations,
clonal cell populations can shift dynamically between
the levels. The expression of the transcription factor
NANOG is probably the most intensively studied
example of this behaviour [16,17,30–32]. Multiple
models have been proposed to explain how the
dynamic switching of NANOG expression occurs, but
as yet none fully captures the effect. Alongside
NANOG, several other ‘pluripotency-related’ tran-
scription factors are also heterogeneously expressed in
mouseES cells, notably KLF4, KLF5 [33,34], REX1
(Zfp42 [35,36]), TBX3 [34], ESRRB [1] and STELLA
(Dppa3) [37].
Cell types as high-dimensional
attractors in gene expression state
space
In a multicellular organism there can be hundreds of
different identifiable cell types, and all of them will
contain the same set of digitally encoded instructions:
the genome. But what is a cell type? As a researcher, it
is possible to class a cell based on its morphology, by
the expression of certain genes, by the context in
which it is found in, and by its behaviour in response
to its environment. However, this does not address cell
identity and the relationship between developmental
lineages at a fundamental level [22,38].
Development is often described as if it is determinis-
tic: zygote becomes morula becomes blastocyst etc.
But, as alluded to above, there is a degree of stochas-
ticity in development which is probably attributable to
a combination of the often small numbers of each
chemical species and biological noise [25,28,39]. This
apparent paradox between developmental predictabil-
ity and stochasticity can be resolved by considering the
behaviour of a cell as a dynamical system [38,40,41].
One way of doing this based purely on gene expression
is to categorize a cell’s type by measuring its gene
expression profile and assigning a cell state, S. The cell
state is jointly defined by the expression of all genes in
the genome x1, x2, . . ., xN, and so each state S = [x1,
x2, . . ., xN] represents a coordinate in state space
(Fig. 1) [38]. Using this dynamical systems conception,
different cell types thus occupy different regions in
state space, and changes in expression are accompa-
nied by the movement of S along one of a set of tra-
jectories. GRNs include many nodes (genes) which
directly influence the expression of other nodes,
namely the transcription factors [42–44]. By nature this
restricts the scope of potential trajectories.
A
B
Fig. 1. ES cell differentiation landscape. Model in which the GRN
is indicated as a 3D surface, with all possible gene expression
combinations existing as discrete coordinates in 2D state space.
Some coordinates (meaning combinations of expression patterns)
are more likely or more stable than others, and are called
‘attractors’. For example, in (A) positions 1 and 2 indicate stable or
highly probable attractor states, whereas position 3 indicates a
very unstable/unlikely position. Position 1 in (A) represents self-
renewing cells in 2i/LIF conditions and position 2 represents ES
cells in serum/LIF conditions. Upon loss of self-renewal signals (B),
the resulting GRN no longer favours attractors 1 or 2, which
become very unstable. In contrast attractors 4, 5 and 6 have
become more stable and can attract cells traversing the landscape.
These would represent entry points into different differentiation
pathways. During normal development cells can only move from
left to right in this model. Moving from right to left would only
occur during experimental reprogramming. NuRD activity is
predicted to limit the depth of the attractors and/or define the
trajectories, displayed here as troughs, between attractors. PRC2
function is proposed to be required to stabilize/maintain the
attractors.
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We can consider that, due to gene expression noise,
the expression of any gene xi will fluctuate, and so the
cell state S will move around in state space. If all
genes were independent of each other, then S could be
found at any coordinate. However, in biological sys-
tems, genes are not regulated totally independently of
one another. In fact, there is a very high degree of
inter-regulation, meaning that certain gene expression
states are possible or even likely, whilst others are
close to impossible to achieve. Thus, there are areas of
state space which are more and less likely to be
explored (Fig. 1). Of the more likely areas of state
space, there are points where all regulatory interac-
tions are satisfied. These are stable points called attrac-
tors [38,40]. Once in an attractor, small perturbations
in gene expression will not cause xi to fluctuate too
much, and so S is likely to fall back to the centre of
the attractor. Large perturbations allow S to transit
out of the basin of attraction, possibly towards
another attractor. In this model, each different cell
type would be an attractor in an ever evolving land-
scape of attractors [22].
The connections between nodes within the GRN can
have a profound effect on the potential phenotypes of a
cell and can influence the manner in which the cell can
change phenotypes and differentiate. The attractor
states encoded within the GRN topology are perhaps
the most fundamental defining feature of cell type [24].
Next, we consider how chromatin modifying complexes
can act upon the GRN, how they aid the transitions
between cell types and how they allow the stabilization
and establishment of differentiated cell types.
Chromatin modifying complexes and
the dynamics of the GRN
Here, we ask what role or roles a chromatin modifying
complex occupies during the differentiation of cells,
specifically ES cells. For the most part, the roles of
chromatin modifying complexes have been described
based on their physical effect on the chromatin. We
can reduce differentiation and development to two
central requirements: (a) the cell state must be able to
transition from one stable state to another, with the
differentiated state having some new ability (or set of
abilities) required for further survival and/or growth;
(b) the further transitions [i.e. further differentiation or
the reverse transition (de-differentiation)] should nor-
mally be difficult to achieve, unless the correct envi-
ronmental cues are present. We will refer to these two
requirements as ‘transition’ and ‘establishment’.
We can think of differentiation as occurring when
there is a bifurcation in phase space, i.e. something
changes which causes a qualitative change in the
behaviour of the system. Intuitively, chromatin remo-
dellers could facilitate these bifurcation events in two
broad ways. First, chromatin modifying complexes
generally associate with a huge number of genetic con-
trol elements (promoters, enhancers etc.), and so their
effect is felt at all points across the GRN. However,
they also tend to have a high degree of specificity, and
it is often observed (and assumed) that this specificity
is mediated by complex transcription factor interac-
tions. If this is so, chromatin modifiers should have a
role in mediating the connections between nodes in the
GRN. In doing this, the trajectories that a cell can
take to move through phase space would be deter-
mined to some degree by chromatin modifying com-
plexes. This could be seen as a form of intrinsic
control over the transition stage of differentiation.
Second, genes within heterochromatic regions can-
not be expressed. A gene in this condition has been
effectively removed from the GRN, and the GRN has
effectively been shrunk. In this establishment step, we
would now expect the nature of the attractor states to
change and for the reverse transition to be energeti-
cally unfavourable.
Considering cell states and developmental transition
in this way allows us to predict phenotypes arising
from various scenarios: if the transition is difficult, the
cells will appear resistant to differentiation; if the
establishment is difficult, the cells will be able to differ-
entiate but appear to fail to commit to a new state; if
too much of the required GRN is removed, then the
cell may die or adopt a qualitatively wrong cell state;
if too little of the GRN is turned off, then the cell
may adopt a qualitatively wrong state.
We shall now explore how the mutant phenotypes
of cells lacking two well-studied chromatin modifying
complexes (NuRD and PRC2) would fit these descrip-
tions and what possible further insights these would
offer (for detailed reviews of the molecular biology of
these complexes, see [5,9,10]).
The NuRD complex
The NuRD complex is a multi-protein complex which
is abundant in mammalian cells [45–47]. Its biochemi-
cally defined roles are to remodel chromatin and to de-
acetylate histones. Indeed, based on this histone
deacetylase activity, it has commonly been referred to
as a transcriptional co-repressor complex [45,47]. How-
ever, more recent evidence suggests that the presence
of the complex at a gene locus is just as likely to be
associated with active transcription as repressed tran-
scription [48–51].
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Mouse ES cells lacking the NuRD complex are, to
an extent, stuck in the ‘ES’ cell state. That is, they
self-renew but struggle to differentiate. Similarly,
in vivo, NuRD-null epiblast cells fail to develop, result-
ing in failure to form the embryo proper. Whereas
wild-type ES cells cultured in standard self-renewal
conditions differentiate within two to three generations
after withdrawal of leukaemia inhibitory factor (LIF),
NuRD-deficient ES cells will continue to self-renew
indefinitely [52]. Additionally, under standard ES cell
culture conditions, wild-type-ES cell cultures consist of
a heterogeneous mix of self-renewing and spontane-
ously differentiating cells, whereas NuRD-mutant ES
cells do not show any signs of spontaneous differentia-
tion. The NuRD complex also appears to have a high-
level role in creating ES cell heterogeneity; one of the
features of the NuRD-mutant ES cell phenotype is a
loss of certain subpopulations as defined by transcrip-
tion factor protein levels [34].
Where does NuRD function fit within our model of
differentiation as a transition between stable states
within the GRN? The NuRD complex (like all chroma-
tin remodelling complexes) can be considered to be a
general purpose tool which is employed by transcrip-
tion factors at various gene loci to modify chromatin
structure [53,54], acting globally to define the overall
shape of the GRN. In this scenario, loss of the NuRD
complex (or of any other chromatin remodelling com-
plex) would alter the topology of the network. In the
case of mouse pluripotent cells, absence of NuRD cre-
ates a more stable, more uniform ‘self-renewing’ state,
where the probability that a cell can leave this state is
much reduced. Thus NuRD can normally be considered
to function to limit the stability of this pluripotent cell
state, either by controlling the ‘depth’ of the ES cell
state or by facilitating the transition away from the plu-
ripotent cell state upon loss of self-renewal signals.
Could NuRD also be important for cells to main-
tain the identity of secondary cell states, i.e. those cells
into which pluripotent cells differentiate? We find this
to be less likely. One reason for this is that the
NuRD-dependent differentiation seen in ES cells is
context-dependent: under normal differentiation condi-
tions, i.e. those to which pluripotent cells are exposed
in an implantation-stage embryo, NuRD function is
required for differentiation. In other contexts, such as
upon treatment with differentiation-inducing drugs,
injection under an adult kidney capsule or induction
towards a trophectoderm fate, NuRD-deficient cells
readily differentiate [52,55–57]. Further, while NuRD
function is required for ES cells to form neural pro-
genitor cells in culture, loss of NuRD in established
neural progenitor cultures does not impair mainte-
nance of these cells [52,58]. Therefore we favour a sce-
nario in which control of gene expression by the
NuRD complex is not important for maintaining the
identity of somatic cell types. These examples also
indicate that NuRD function is not absolutely required
to define differentiation trajectories as, if given suffi-
ciently strong extracellular signals, cells are able to find
their way along a differentiation path. This is entirely
consistent with NuRD defining the topology of the
GRN, making the differentiation paths accessible to a
pluripotent cell under normal, physiological condi-
tions. However, if these cells are exposed to signals
normally only seen much later in development (e.g.
retinoic acid, or the extracellular milieu surrounding a
kidney capsule), then this is sufficient to override any
NuRD dependence upon differentiation.
Studies in somatic stem cell types support the notion
that NuRD function defines the trajectories between
cell states, but not that it influences the stability of a
stem cell state. The founding NuRD component pro-
tein CHD4 (Mi-2b) has been shown to be important
for developmental transitions in embryonic skin, i.e.
for the normal progression of one epidermal progeni-
tor cell to differentiate into another [59]. Similarly,
deletion of Chd4 in haematopoietic stem cells prevents
neither self-renewal nor exiting the stem cell state;
however, these stem cells produce an inappropriate
mix of progenitor cell types [60]. Loss of the NuRD
scaffold protein MBD3 during neural development
results in a failure of neural progenitors to produce a
normal complement of downstream cell types (Knock
et al., in revision). Whilst it certainly is the case that
the NuRD complex has tissue-specific behaviours and
conformations [61–64], these studies are consistent
with NuRD functioning to define differentiation trajec-
tories in a number of different mammalian cell types.
PRC2 and bivalent chromatin
PRC2 plays an essential role during embryonic devel-
opment in mice and, indeed, in most other character-
ized metazoans (see for a recent review [10]). In mice,
lack of the core PRC2 components EED, EZH2 or
SUZ12 results in embryonic failure during the eighth
or ninth day of development [65–67], placing its essen-
tial function slightly later than that of NuRD, which is
required during the fifth day of development [55].
PRC2 maintains genes in a repressed state via the di-
and tri-methylation of histone H3 at lysine 27 [68]. It
has been noted that this mark, which is associated
with transcriptional silencing, can coexist on promot-
ers with a mark of actively transcribed genes,
H3K4Me3, in a so-called ‘bivalent’ chromatin state
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[69–71]. Although this bivalent chromatin status was
initially identified in mouseES cells and therefore
thought to be a hallmark of stem cells, it was subse-
quently shown to also exist in differentiated cell types
and is thus not a stem-cell-specific phenomenon
[72,73].
The bivalent domain was first postulated to be a
mark of promoters for which transcription was poised:
not fully active (hence the H3K27Me3) and not fully
repressed (due to the presence of H3K4Me3), but
could quickly be turned either on or off depending
upon which signals were received by the cell [71]. In
this model of H3K27Me3 function, PRC2 could be
seen to act to ensure cells remained responsive to dif-
ferentiation signals, rather like the function described
for NuRD above. Yet unlike NuRD, PRC2 compo-
nents are not required for cells to exit the pluripotent
state or for the onset of gastrulation during mouse
embryogenesis [65–67]. Indeed, careful analyses of
early epiblast cells in gastrulating embryos found that
EED was not necessary for cells crossing the primitive
streak to adopt their normal mesodermal fates, but
defects were found in the function and behaviour of
these resulting PRC2-mutant mesodermal cells [65,74].
These phenotypes do not appear consistent with a
model in which PRC2, and by extension a bivalent
chromatin state, is important for lineage fate choice.
Despite its general acceptance and popularity, a
number of strands of evidence are beginning to cast
doubt on the ‘bivalency-as-developmental poising’
model. ES cells lacking PRC2 components are able to
self-renew without large-scale activation of differentia-
tion-associated genes, demonstrating that PRC2 func-
tion (and, by extension, H3K27Me3) is not strictly
required to prevent activation of this class of genes
[75–78]. Culturing mouseES cells in conditions known
to minimize transcriptional and functional heterogene-
ity, so-called 2i media [13,14], results in a reduction in
global H3K27Me3 but no increase in precocious
expression of lineage-specific transcription [79]. More
compelling evidence came from deletion of the histone
methyltransferase required for deposition of
H3K4Me3 marks specifically at bivalent promoters,
MLL2, which did not result in failure of developmen-
tal gene activation upon induction of ES cell differenti-
ation [80]. This study provides strong genetic evidence
that bivalency per se is not required for developmental
priming of gene expression. A similar result was found
when Mll2 was knocked down in ES cells [81]. The
importance of PRC2 function in early embryonic
development is incontrovertible; however, the evidence
does not support a role in specifying early cell fate
decisions.
So how could the demonstrated function of PRC2 in
mammalian development fit within our model of line-
age commitment as a cell transiting between attractor
states? PRC2 recruitment in ES cells is reliant on the
transcriptional status of its target genes rather than by
the action of any particular transcription factors [82]. It
is associated with specific loci at different points in
development, but this may be as a secondary effect to
the genes being turned off by other means. As such,
unlike NuRD, its primary function would be to main-
tain inactive genes in a silent, unresponsive state, and it
would have less of an influence on the strength of con-
nections within the network. This would serve to effec-
tively remove nodes from the GRN and thus change
the dynamics of the system. In other words, its primary
role would be to maintain the stability (or ensure
proper identity) of a specific cell state.
A function for PRC2 in stabilizing cell states is sup-
ported by the initial suggestion that lack of PRC2
components was incompatible with ES cell self-renewal
[83]. It has subsequently become apparent that these
ES cells actually are able to self-renew but show preco-
cious differentiation and activation of some differentia-
tion markers, i.e. cell state instability. Notably if these
cells are cultured in 2i conditions they become consid-
erably more stable [82]. That PRC2 functions in cell
state stability is further supported by the behaviour of
PRC2-mutant ES cells upon withdrawal of self-renewal
signals. ES cells lacking the PRC2 component SUZ12
initially adopt gene expression profiles similar to their
wild-type counterparts early in differentiation, consis-
tent with them being able to both exit the self-renew-
ing state and begin to transit to a new state (Fig. 1B).
However, after several days they revert to an ES-cell-
like stable state [82]. This observation can be inter-
preted to indicate that without PRC2-mediated main-
tenance of transcriptional silencing the GRN is unable
to properly stabilize in a non-ES-cell-like state.
PRC2 and NuRD combine to define
cell fates
Defining NuRD and PRC2 function in terms of how
they influence the topology of the differentiation land-
scape, it is possible to make predictions about how the
two would work together during differentiation. Spe-
cifically, NuRD activity would facilitate the exit of a
cell from a given attractor state, either by destabilizing
that attractor state or by defining differentiation tra-
jectories, whereas PRC2 would ensure that once the
cell arrives at a new state it would remain there.
One example of just such a partnership between
NuRD and PRC2 is in the silencing of Hox loci in
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Drosophila melanogaster. During development, pro-
teins encoded by the gap genes, such as Hunchback
(Hb), maintain the appropriate spatial expression pat-
terns of Hox gene expression by repressing their tran-
scription outside of normal expression domains [84–86].
The transcriptional repressor Hb recruits the NuRD
component protein dMi-2 to establish transcriptional
silencing at Hox loci [87], thus establishing the posi-
tional identity of a cell. Although this expression
pattern is maintained throughout development, expres-
sion of Hb is quickly lost after this establishment step
and repression at these silenced Hox loci is maintained
by PRC2. In the absence of PRC2 function the correct
positional identity of cells is lost as appropriate Hox
gene expression patterns are not maintained. Thus, in
this case, NuRD and PRC2 act in sequential but sepa-
rate steps of gene repression and cell fate determina-
tion: NuRD is used to establish the expression state,
whereas PRC2 is used to maintain it.
A further example is provided in Caenorhabditis ele-
gans, where orthologues of two NuRD components
(Let418/Chd4 and Hda1/Hdac1) function to facilitate
transition out of the germline state after fertilization
[88]. That is, their activity is important to allow the
genome to properly respond to differentiation signals
which will instruct the fertilized egg to develop into an
embryo, whereas maintenance of the specific cellular
states is carried out, at least in part, by orthologues of
the polycomb group proteins [88]. Remarkably, a simi-
lar function for NuRD component proteins had previ-
ously been described in Arabidopsis thaliana, in that a
Chd4 orthologue was shown to be important to pre-
vent embryonic characteristics in somatic tissues [89–
91].
How might such an order of events work mechanis-
tically? One potential mechanism is provided by the
seemingly complementary enzymatic activities of the
two complexes. Transcriptional repression by NuRD is
associated with loss of acetylation of H3K27, a mark
of active transcription. This deacetylated H3K27 resi-
due then becomes a substrate for the histone methyl-
transferase activity of PRC2, which facilitates mono-,
di- and tri-methylation of H3K27 [92,93]. Therefore
NuRD and PRC2 have the potential to act in tandem
to change an active histone mark to a repressive mark.
This mechanism was shown to occur at a subset of
NuRD and PRC2 target genes in ES cells [94] and
may well occur in somatic cells as well [95].
Genome-wide chromatin binding data in self-renew-
ing mouseES cells show that NuRD components and
PRC2 components colocalize at a relatively small sub-
set of either complex’s array of bound genomic loca-
tions [94]. This could mean that the two complexes do
not tend to be present at the same loci at the same
time, due to the sequential nature of their respective
activities, or it could indicate that the examples
described above represent a relatively infrequent occur-
rence of NuRD–PRC2 functional interaction. In the
latter case we would predict that PRC2 and NuRD
combine with other chromatin modifying protein com-
plexes to carry out the functions described above, with
the identities of these other complexes depending upon
the cell type and lineage decision in question. Further,
NuRD components are more likely to be found at
actively transcribed genes than at silent genes [48–51].
This indicates that, most of the time, mammalian
NuRD does not silence transcription as in the example
of dMi2 and HOX genes in Drosophila, but rather
modulates levels of active transcription [34,48]. There-
fore it makes intuitive sense that only occasionally
would this modulation require enforcement of tran-
scriptional silencing by PRC2.
Concluding remarks – and a get-out
clause
Here we propose a hypothesis to explain how two
chromatin modifying complexes influence the GRN
and thereby function during mammalian development.
This is based upon an existing model of ‘development
as changes in the GRN’, which in turn is designed to
help us better understand the biology we observe. We
are aware that no model can fully describe every
nuance of mammalian development nor take into con-
sideration the >4500 citations in PubMed referring to
NuRD and/or polycomb. The hypothesis we propose
is designed to form a platform upon which to base fur-
ther experiments and, like most good hypotheses, to
be knocked down by clever experiments and replaced
by another hypothesis based upon a more accurate
model. It should also be pointed out that given the
scale of genome-wide data on PRC2 and NuRD bind-
ing events and associated gene expression data, it will
always be possible to find examples where these mod-
els and hypotheses do not hold true. Nevertheless we
argue that these ideas do describe much of the pheno-
typic data present in the literature and are therefore
useful.
The packaging of DNA into chromatin was a hugely
important innovation in the evolution of eukaryotic
organisms, and the regulation of chromatin has been
shown time and again to be of crucial importance to
cell survival and decision making. What has been less
well explored is the role of chromatin repressive com-
plexes in the regulation of the dynamics of the GRN.
Admittedly, the dynamics of cell decision making is
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something of an open question, with suggestions and
demonstrations of switching behaviours and oscilla-
tions at the local level, to critical-like self-organization
at the level of the whole network [96,97]. What we
have hoped to demonstrate is that, by stepping back
from the molecular details, we may be able to under-
stand the higher-level functions of these molecular
machines and thereby better understand how the enzy-
matic activities contained within these complexes are
harnessed to facilitate metazoan development.
There are a number of strands of thought that lead
from this point. Much of the ability of a cell to com-
pute decisions is presumed to be based on the dynam-
ics of the system [98]. In a GRN, chromatin repressive
complexes influence the expression of a large number
of genes, placing them at the heart of cellular decision
making. Therefore it is hoped that by concentrating
on the higher-level effects of chromatin regulation in
phase space we may gain entirely new insights into the
use and evolution of chromatin-mediated regulation of
cell fate decisions.
Acknowledgements
We would like to thank members of the BH Lab, past
and present, for stimulating discussions and for critical
reading of the manuscript. Work in the BH Lab is
supported by a Wellcome Trust Senior Research Fel-
lowship in the Basic Biomedical Sciences held by BH,
and by the Wellcome Trust – Medical Research Coun-
cil Stem Cell Institute. JS was funded as a PhD stu-
dent by the UK Medical Research Council during part
of this work.
Author contributions
JS and BH both conceived the idea and wrote the
manuscript.
References
1 Nichols J & Smith A (2012) Pluripotency in the embryo
and in culture. Cold Spring Harb Perspect Biol 4,
a008128.
2 Daley GQ & Scadden DT (2008) Prospects for stem
cell-based therapy. Cell 132, 544–548.
3 Ferreira LM & Mostajo-Radji MA (2013) How induced
pluripotent stem cells are redefining personalized
medicine. Gene 520, 1–6.
4 Pourquie O, Bruneau B, Gotz M, Keller G & Smith A
(2013) Stem cells and regeneration: a special issue.
Development (Cambridge, England) 140, 2445.
5 Clapier CR & Cairns BR (2009) The biology of
chromatin remodeling complexes. Annu Rev Biochem
78, 273–304.
6 Iyer VR (2012) Nucleosome positioning: bringing order
to the eukaryotic genome. Trends Cell Biol 22, 250–256.
7 Struhl K & Segal E (2013) Determinants of nucleosome
positioning. Nat Struct Mol Biol 20, 267–273.
8 O’Shaughnessy A & Hendrich B (2013) CHD4 in the
DNA-damage response and cell cycle progression: not
so NuRDy now. Biochem Soc Trans 41, 777–782.
9 Lessard JA & Crabtree GR (2010) Chromatin
regulatory mechanisms in pluripotency. Annu Rev Cell
Dev Biol 26, 503–532.
10 Laugesen A & Helin K (2014) Chromatin repressive
complexes in stem cells, development, and cancer. Cell
Stem Cell 14, 735–751.
11 Paul S & Knott JG (2014) Epigenetic control of cell
fate in mouse blastocysts: the role of covalent histone
modifications and chromatin remodeling. Mol Reprod
Dev 81, 171–182.
12 Bird A (2002) DNA methylation patterns and
epigenetic memory. Genes Dev 16, 6–21.
13 Wray J, Kalkan T & Smith AG (2010) The ground
state of pluripotency. Biochem Soc Trans 38, 1027–
1032.
14 Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble
B, Woodgett J, Cohen P & Smith A (2008) The ground
state of embryonic stem cell self-renewal. Nature 453,
519–523.
15 Canham MA, Sharov AA, Ko MS & Brickman JM
(2010) Functional heterogeneity of embryonic stem cells
revealed through translational amplification of an early
endodermal transcript. PLoS Biol 8, e1000379.
16 Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B,
Robertson M, Vrana J, Jones K, Grotewold L & Smith
A (2007) Nanog safeguards pluripotency and mediates
germline development. Nature 450, 1230–1234.
17 Kalmar T, Lim C, Hayward P, Munoz-Descalzo S,
Nichols J, Garcia-Ojalvo J & Martinez Arias A (2009)
Regulated fluctuations in nanog expression mediate cell
fate decisions in embryonic stem cells. PLoS Biol 7,
e1000149.
18 Wu J & Tzanakakis ES (2013) Deconstructing stem cell
population heterogeneity: single-cell analysis and
modeling approaches. Biotechnol Adv 31, 1047–1062.
19 Martinez Arias A & Brickman JM (2011) Gene
expression heterogeneities in embryonic stem cell
populations: origin and function. Curr Opin Cell Biol
23, 650–656.
20 Raj A & van Oudenaarden A (2008) Nature, nurture,
or chance: stochastic gene expression and its
consequences. Cell 135, 216–226.
21 Kobayashi T, Mizuno H, Imayoshi I, Furusawa C,
Shirahige K & Kageyama R (2009) The cyclic gene
8 ª The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS.
Chromatin modifiers in lineage commitment J. Signolet and B. Hendrich
Hes1 contributes to diverse differentiation responses of
embryonic stem cells. Genes Dev 23, 1870–1875.
22 Huang S (2009) Reprogramming cell fates: reconciling
rarity with robustness. BioEssays 31, 546–560.
23 Arriaga EA (2009) Determining biological noise via
single cell analysis. Anal Bioanal Chem 393, 73–80.
24 Huang S (2009) Non-genetic heterogeneity of cells in
development: more than just noise. Development
(Cambridge, England) 136, 3853–3862.
25 Maheshri N & O’Shea EK (2007) Living with noisy
genes: how cells function reliably with inherent
variability in gene expression. Annu Rev Biophys Biomol
Struct 36, 413–434.
26 Elowitz MB, Levine AJ, Siggia ED & Swain PS (2002)
Stochastic gene expression in a single cell. Science (New
York, NY) 297, 1183–1186.
27 Newman JR, Ghaemmaghami S, Ihmels J, Breslow
DK, Noble M, DeRisi JL & Weissman JS (2006)
Single-cell proteomic analysis of S. cerevisiae reveals the
architecture of biological noise. Nature 441, 840–846.
28 Raser JM & O’Shea EK (2004) Control of stochasticity
in eukaryotic gene expression. Science (New York, NY)
304, 1811–1814.
29 Morelli MJ, Allen RJ & Wolde PR (2011) Effects of
macromolecular crowding on genetic networks. Biophys
J 101, 2882–2891.
30 Faddah DA, Wang H, Cheng AW, Katz Y, Buganim Y
& Jaenisch R (2013) Single-cell analysis reveals that
expression of nanog is biallelic and equally variable as
that of other pluripotency factors in mouse ESCs. Cell
Stem Cell 13, 23–29.
31 Filipczyk A, Gkatzis K, Fu J, Hoppe PS, Lickert H,
Anastassiadis K & Schroeder T (2013) Biallelic
expression of nanog protein in mouse embryonic stem
cells. Cell Stem Cell 13, 12–13.
32 Miyanari Y & Torres-Padilla ME (2012) Control of
ground-state pluripotency by allelic regulation of
Nanog. Nature 483, 470–473.
33 Niwa H, Ogawa K, Shimosato D & Adachi K (2009) A
parallel circuit of LIF signalling pathways maintains
pluripotency of mouse ES cells. Nature 460, 118–122.
34 Reynolds N, Latos P, Hynes-Allen A, Loos R, Leaford
D, O’Shaughnessy A, Mosaku O, Signolet J, Brennecke
P, Kalkan T et al. (2012) NuRD suppresses
pluripotency gene expression to promote transcriptional
heterogeneity and lineage commitment. Cell Stem Cell
10, 583–594.
35 Toyooka Y, Shimosato D, Murakami K, Takahashi
K & Niwa H (2008) Identification and
characterization of subpopulations in undifferentiated
ES cell culture. Development (Cambridge, England)
135, 909–918.
36 Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook
A, Kemler R & Smith A (2011) Inhibition of glycogen
synthase kinase-3 alleviates Tcf3 repression of the
pluripotency network and increases embryonic stem cell
resistance to differentiation. Nat Cell Biol 13, 838–845.
37 Hayashi K, Lopes SM, Tang F & Surani MA (2008)
Dynamic equilibrium and heterogeneity of mouse
pluripotent stem cells with distinct functional and
epigenetic states. Cell Stem Cell 3, 391–401.
38 Huang S (2010) Cell lineage determination in state
space: a systems view brings flexibility to dogmatic
canonical rules. PLoS Biol 8, e1000380.
39 Chang HH, Hemberg M, Barahona M, Ingber DE &
Huang S (2008) Transcriptome-wide noise controls
lineage choice in mammalian progenitor cells. Nature
453, 544–547.
40 Huang S, Ernberg I & Kauffman S (2009) Cancer
attractors: a systems view of tumors from a gene
network dynamics and developmental perspective.
Semin Cell Dev Biol 20, 869–876.
41 Wang J, Xu L, Wang E & Huang S (2010) The
potential landscape of genetic circuits imposes the
arrow of time in stem cell differentiation. Biophys J 99,
29–39.
42 Levy SF & Siegal ML (2008) Network hubs buffer
environmental variation in Saccharomyces cerevisiae.
PLoS Biol 6, e264.
43 Lu R, Markowetz F, Unwin RD, Leek JT, Airoldi EM,
MacArthur BD, Lachmann A, Rozov R, Ma’ayan A,
Boyer LA et al. (2009) Systems-level dynamic analyses
of fate change in murine embryonic stem cells. Nature
462, 358–362.
44 Ng HH & Surani MA (2011) The transcriptional and
signalling networks of pluripotency. Nat Cell Biol 13,
490–496.
45 Ahringer J (2000) NuRD and SIN3 histone deacetylase
complexes in development. Trends Genet 16, 351–356.
46 Allen HF, Wade PA & Kutateladze TG (2013) The
NuRD architecture. Cell Mol Life Sci 70, 3513–3524.
47 McDonel P, Costello I & Hendrich B (2009) Keeping
things quiet: roles of NuRD and Sin3 co-repressor
complexes during mammalian development. Int J
Biochem Cell Biol 41, 108–116.
48 Reynolds N, O’Shaughnessy A & Hendrich B (2013)
Transcriptional repressors: multifaceted regulators of
gene expression. Development (Cambridge, England)
140, 505–512.
49 Shimbo T, Du Y, Grimm SA, Dhasarathy A, Mav D,
Shah RR, Shi H & Wade PA (2013) MBD3 localizes at
promoters, gene bodies and enhancers of active genes.
PLoS Genet 9, e1004028.
50 Baubec T, Ivanek R, Lienert F & Schubeler D (2013)
Methylation-dependent and -independent genomic
targeting principles of the MBD protein family. Cell
153, 480–492.
51 Gunther K, Rust M, Leers J, Boettger T, Scharfe M,
Jarek M, Bartkuhn M & Renkawitz R (2013)
Differential roles for MBD2 and MBD3 at methylated
ª The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS. 9
J. Signolet and B. Hendrich Chromatin modifiers in lineage commitment
CpG islands, active promoters and binding to exon
sequences. Nucleic Acids Res 41, 3010–3021.
52 Kaji K, Caballero IM, MacLeod R, Nichols J, Wilson
VA & Hendrich B (2006) The NuRD component Mbd3
is required for pluripotency of embryonic stem cells.
Nat Cell Biol 8, 285–292.
53 Narlikar GJ, Sundaramoorthy R & Owen-Hughes T
(2013) Mechanisms and functions of ATP-dependent
chromatin-remodeling enzymes. Cell 154, 490–503.
54 Morris SA, Baek S, Sung MH, John S, Wiench M,
Johnson TA, Schiltz RL & Hager GL (2014)
Overlapping chromatin-remodeling systems collaborate
genome wide at dynamic chromatin transitions. Nat
Struct Mol Biol 21, 73–81.
55 Kaji K, Nichols J & Hendrich B (2007) Mbd3, a
component of the NuRD co-repressor complex, is
required for development of pluripotent cells.
Development (Cambridge, England) 134, 1123–1132.
56 Latos PA, Helliwell C, Mosaku O, Dudzinska DA,
Stubbs B, Berdasco M, Esteller M & Hendrich B (2012)
NuRD-dependent DNA methylation prevents ES cells
from accessing a trophectoderm fate. Biol Open 1, 341–
352.
57 Zhu D, Fang J, Li Y & Zhang J (2009) Mbd3, a
component of NuRD/Mi-2 complex, helps maintain
pluripotency of mouse embryonic stem cells by
repressing trophectoderm differentiation. PLoS One 4,
e7684.
58 dos Santos RL, Tosti L, Radzisheuskaya A, Caballero
IM, Kaji K, Hendrich B & Silva JC (2014) MBD3/
NuRD facilitates induction of pluripotency in a
context-dependent manner. Cell Stem Cell 15, 102–110.
59 Kashiwagi M, Morgan BA & Georgopoulos K (2007)
The chromatin remodeler Mi-2beta is required for
establishment of the basal epidermis and normal
differentiation of its progeny. Development (Cambridge,
England) 134, 1571–1582.
60 Yoshida T, Hazan I, Zhang J, Ng SY, Naito T,
Snippert HJ, Heller EJ, Qi X, Lawton LN, Williams CJ
et al. (2008) The role of the chromatin remodeler Mi-2
{beta} in hematopoietic stem cell self-renewal and
multilineage differentiation. Genes Dev 22, 1174–1189.
61 Mazumdar A, Wang RA, Mishra SK, Adam L,
Bagheri-Yarmand R, Mandal M, Vadlamudi RK &
Kumar R (2001) Transcriptional repression of
oestrogen receptor by metastasis-associated protein 1
corepressor. Nat Cell Biol 3, 30–37.
62 Schmitt C, Tonnelle C, Dalloul A, Chabannon C,
Debre P & Rebollo A (2002) Aiolos and Ikaros:
regulators of lymphocyte development, homeostasis and
lymphoproliferation. Apoptosis 7, 277–284.
63 Bowen NJ, Fujita N, Kajita M & Wade PA (2004)
Mi-2/NuRD: multiple complexes for many purposes.
Biochim Biophys Acta 1677, 52–57.
64 Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno
CS & Wade PA (2003) MTA3, a Mi-2/NuRD complex
subunit, regulates an invasive growth pathway in breast
cancer. Cell 113, 207–219.
65 Faust C, Schumacher A, Holdener B & Magnuson T
(1995) The eed mutation disrupts anterior mesoderm
production in mice. Development (Cambridge, England)
121, 273–285.
66 O’Carroll D, Erhardt S, Pagani M, Barton SC, Surani
MA & Jenuwein T (2001) The polycomb-group gene
Ezh2 is required for early mouse development. Mol Cell
Biol 21, 4330–4336.
67 Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E
& Helin K (2004) Suz12 is essential for mouse
development and for EZH2 histone methyltransferase
activity. EMBO J 23, 4061–4071.
68 Margueron R & Reinberg D (2011) The Polycomb
complex PRC2 and its mark in life. Nature 469, 343–
349.
69 Voigt P, LeRoy G, Drury WJ III, Zee BM, Son J, Beck
DB, Young NL, Garcia BA & Reinberg D (2012)
Asymmetrically modified nucleosomes. Cell 151, 181–
193.
70 Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen
HF, John RM, Gouti M, Casanova M, Warnes G,
Merkenschlager M et al. (2006) Chromatin signatures
of pluripotent cell lines. Nat Cell Biol 8, 532–538.
71 Bernstein BE, Mikkelsen TS, Xie X, Kamal M,
Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M,
Plath K et al. (2006) A bivalent chromatin structure
marks key developmental genes in embryonic stem cells.
Cell 125, 315–326.
72 Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E,
Giannoukos G, Alvarez P, Brockman W, Kim TK,
Koche RP et al. (2007) Genome-wide maps of
chromatin state in pluripotent and lineage-committed
cells. Nature 448, 553–560.
73 Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H,
Jonsdottir GA, Stewart R & Thomson JA (2007)
Whole-genome analysis of histone H3 lysine 4 and
lysine 27 methylation in human embryonic stem cells.
Cell Stem Cell 1, 299–312.
74 Faust C, Lawson KA, Schork NJ, Thiel B &
Magnuson T (1998) The Polycomb-group gene eed is
required for normal morphogenetic movements during
gastrulation in the mouse embryo. Development
(Cambridge, England) 125, 4495–4506.
75 Pasini D, Bracken A, Hansen J, Capillo M & Helin K
(2007) The polycomb group protein Suz12 Is required
for embryonic stem cell differentiation. Mol Cell Biol
27, 3769–3779.
76 Williams RR, Azuara V, Perry P, Sauer S, Dvorkina
M, Jorgensen H, Roix J, McQueen P, Misteli T,
Merkenschlager M et al. (2006) Neural induction
10 ª The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS.
Chromatin modifiers in lineage commitment J. Signolet and B. Hendrich
promotes large-scale chromatin reorganisation of the
Mash1 locus. J Cell Sci 119, 132–140.
77 Chamberlain SJ, Yee D & Magnuson T (2008)
Polycomb repressive complex 2 is dispensable for
maintenance of embryonic stem cell pluripotency. Stem
Cells 26, 1496–1505.
78 Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X,
Yuan G & Orkin SH (2008) EZH1 mediates
methylation on histone H3 lysine 27 and complements
EZH2 in maintaining stem cell identity and executing
pluripotency. Mol Cell 32, 491–502.
79 Marks H, Kalkan T, Menafra R, Denissov S, Jones K,
Hofemeister H, Nichols J, Kranz A, Stewart AF, Smith
A et al. (2012) The transcriptional and epigenomic
foundations of ground state pluripotency. Cell 149,
590–604.
80 Denissov S, Hofemeister H, Marks H, Kranz A, Ciotta
G, Singh S, Anastassiadis K, Stunnenberg HG &
Stewart AF (2014) Mll2 is required for H3K4
trimethylation on bivalent promoters in embryonic stem
cells, whereas Mll1 is redundant. Development
(Cambridge, England) 141, 526–537.
81 Hu D, Garruss AS, Gao X, Morgan MA, Cook M,
Smith ER & Shilatifard A (2013) The Mll2 branch of
the COMPASS family regulates bivalent promoters in
mouse embryonic stem cells. Nat Struct Mol Biol 20,
1093–1097.
82 Riising EM, Comet I, Leblanc B, Wu X, Johansen JV
& Helin K (2014) Gene silencing triggers polycomb
repressive complex 2 recruitment to CpG islands
genome wide. Mol Cell 55, 347–360.
83 Boyer LA, Plath K, Zeitlinger J, Brambrink T,
Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar
A, Ray MK et al. (2006) Polycomb complexes repress
developmental regulators in murine embryonic stem
cells. Nature 441, 349–353.
84 Bienz M & Muller J (1995) Transcriptional silencing of
homeotic genes in Drosophila. BioEssays 17, 775–784.
85 White RA & Lehmann R (1986) A gap gene,
hunchback, regulates the spatial expression of
Ultrabithorax. Cell 47, 311–321.
86 Struhl G & Akam M (1985) Altered distributions of
Ultrabithorax transcripts in extra sex combs mutant
embryos of Drosophila. EMBO J 4, 3259–3264.
87 Kehle J, Beuchle D, Treuheit S, Christen B, Kennison
JA, Bienz M & M€uller J (1998) dMi-2, a hunchback-
interacting protein that functions in Polycomb
repression. Science (New York, NY) 282, 1897–1900.
88 Unhavaithaya Y, Shin TH, Miliaras N, Lee J, Oyama
T & Mello CC (2002) MEP-1 and a homolog of the
NURD complex component Mi-2 act together to
maintain germline-soma distinctions in C. elegans. Cell
111, 991–1002.
89 Eshed Y, Baum SF & Bowman JL (1999) Distinct
mechanisms promote polarity establishment in carpels
of Arabidopsis. Cell 99, 199–209.
90 Ogas J, Cheng JC, Sung ZR & Somerville C (1997)
Cellular differentiation regulated by gibberellin in the
Arabidopsis thaliana pickle mutant. Science (New York,
NY) 277, 91–94.
91 Ogas J, Kaufmann S, Henderson J & Somerville C
(1999) PICKLE is a CHD3 chromatin-remodeling
factor that regulates the transition from embryonic to
vegetative development in Arabidopsis. Proc Natl Acad
Sci USA 96, 13839–13844.
92 Ferrari KJ, Scelfo A, Jammula S, Cuomo A, Barozzi I,
Stutzer A, Fischle W, Bonaldi T & Pasini D (2014)
Polycomb-dependent H3K27me1 and H3K27me2
regulate active transcription and enhancer fidelity. Mol
Cell 53, 49–62.
93 Morey L & Helin K (2010) Polycomb group protein-
mediated repression of transcription. Trends Biochem
Sci 35, 323–332.
94 Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A,
Balasooriya G, Leaford D, Behrens A, Bertone P &
Hendrich B (2012) NuRD-mediated deacetylation of
H3K27 facilitates recruitment of Polycomb Repressive
Complex 2 to direct gene repression. EMBO J 31, 593–605.
95 Morey L, Brenner C, Fazi F, Villa R, Gutierrez A,
Buschbeck M, Nervi C, Minucci S, Fuks F & Di Croce
L (2008) MBD3, a component of the NuRD complex,
facilitates chromatin alteration and deposition of
epigenetic marks. Mol Cell Biol 28, 5912–5923.
96 Halley JD, Burden FR & Winkler DA (2009) Stem cell
decision making and critical-like exploratory networks.
Stem Cell Res 2, 165–177.
97 Torres-Sosa C, Huang S & Aldana M (2012) Criticality
is an emergent property of genetic networks that exhibit
evolvability. PLoS Comput Biol 8, e1002669.
98 Balazsi G, van Oudenaarden A & Collins JJ (2011)
Cellular decision making and biological noise: from
microbes to mammals. Cell 144, 910–925.
ª The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS. 11
J. Signolet and B. Hendrich Chromatin modifiers in lineage commitment
